OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $738 | -19.8% | 59,773 | -41.3% | 0.06% | -31.5% |
| Q2 2023 | $920 | +15.0% | 101,840 | -55.8% | 0.09% | +16.5% |
| Q1 2023 | $800 | +40.8% | 230,632 | -0.4% | 0.08% | +12.9% |
| Q4 2022 | $568 | -99.8% | 231,633 | +122.5% | 0.07% | +84.2% |
| Q3 2022 | $287,000 | -6.8% | 104,084 | +44.0% | 0.04% | -7.3% |
| Q1 2022 | $308,000 | -18.3% | 72,287 | +79.7% | 0.04% | -12.8% |
| Q4 2021 | $377,000 | – | 40,227 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $103,181,000 | 7.44% |
| BVF INC/IL | 6,661,503 | $183,591,000 | 7.16% |
| VR Adviser, LLC | 1,536,193 | $42,337,000 | 5.44% |
| Cormorant Asset Management, LP | 3,073,485 | $84,705,000 | 3.44% |
| GREAT POINT PARTNERS LLC | 329,086 | $9,070,000 | 2.11% |
| Vivo Capital, LLC | 1,238,575 | $34,135,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 150,500 | $4,148,000 | 1.46% |
| Foresite Capital Management IV, LLC | 342,030 | $9,426,000 | 1.39% |
| RA Capital Management | 2,150,404 | $59,265,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 338,381 | $9,326,000 | 0.78% |